C-36 | In-hospital Outcomes Post-TAVR in Patients with Amyloidosis – A Perspective from National Inpatient Sample

Abstract

As many as 15% of patients with aortic stenosis (AS) have underlying amyloidosis. However, there is scarce data on the outcome of patients with AS and amyloidosis after transaortic valve replacement (TAVR), and studies suggest that this population may have a higher risk for procedural complications due to the fragility of amyloid infiltrated tissue.